Skip to main content

Fernando Martínez Valle

Institutions of which they are part

Systemic Diseases
Vall Hebron Institut de Recerca

Fernando Martínez Valle

Institutions of which they are part

Systemic Diseases
Vall Hebron Institut de Recerca

Projects

Ajuts Grups de Recerca (SGR) 2022

IP: Jaume Alijotas Reig
Collaborators: Moisés Labrador Horrillo, Carmen Pilar Simeón i Aznar, Anna Sala Cunill, Roser Solans Laque, Segundo Bujan Rivas, Mar Guilarte Clavero, Vicenç Fonollosa Pla, Fernando Martínez Valle, Victòria Cardona Dahl, Francesc Miro Mur, Alfredo Guillen Del Castillo, Albert Selva O'Callaghan, José Pardos Gea, Laura Donaire Lancharro, Ariadna Anunciacion Llunell
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 00048
Duration: 01/01/2022 - 30/06/2025

Sumoylation in TTR Amyloidosis. Effect of Tafamidis in patients affected with TTR-Amyloidosis

IP: Fernando Martínez Valle
Collaborators: -
Funding agency: Pfizer Limited
Funding: 60507.02
Reference: ASPIRE_WI216783-PFIZER2016
Duration: 01/05/2017 - 31/05/2018

Autoimmunitat i Malaltia Trombòtica (GRC)

IP: Miguel Vilardell Tarres
Collaborators: Carmen Pilar Simeón i Aznar, Roser Solans Laque, Segundo Bujan Rivas, Vicenç Fonollosa Pla, José Ordi Ros, Josefina Cortes Hernandez, Fernando Martínez Valle, Albert Selva O'Callaghan, Cristina Solé Marce
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 329
Duration: 01/01/2014 - 31/12/2016

Determinación del riesgo de afectación extraglandular y desarrollo de linfoma en el Síndrome de Sjögren primario mediante estudio de poblaciones linfocitarias y citocinas en sangre y tejido

IP: Roser Solans Laque
Collaborators: Carlos Palacio García, Margarita Alberola Ferranti, Fernando Martínez Valle
Funding agency: Instituto de Salud Carlos III
Funding: 35695
Reference: PI13/00655
Duration: 01/01/2014 - 30/06/2018

Related news

The new technology allows more sensitive detection of scleroderma patients' autoantibodies, which are related to the severity and progression of the disease.

Researchers have used an innovative protocol to identify people with this autoimmune disease who have a higher risk of cancer.

It will allow the promotion of research on systemic autoimmune-based diseases that especially affect women of childbearing age and, therefore, can also appear during pregnancy.

Related professionals

Mª Teresa Gené Juyent

Mª Teresa Gené Juyent

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Pamela Patricia Yesquen Salcedo

Pamela Patricia Yesquen Salcedo

Research technician
Growth and Development
Read more
Cleofé Romagosa Pérez-Portabell

Cleofé Romagosa Pérez-Portabell

Main researcher
Translational Molecular Pathology
Read more
Alexandre García Pérez

Alexandre García Pérez

Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.